Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00315601 · ClinicalTrials.gov registry record · Phase 4
Intrapulmonary Pharmacokinetics of Antibiotics
A Phase 4 study, sponsored by University of Illinois at Chicago.
- Terminated
- Registry status
- Phase 4
- Development phase
- 35
- Enrollment target
NCT00315601 is a Phase 4 study that was terminated before completion, run by University of Illinois at Chicago. The registered enrollment target is 35 participants.
The verdict
NCT00315601, a Phase 4 study, was terminated before completion, sponsored by University of Illinois at Chicago.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 35 participants
- Enrollment target
Study Summary
The major objectives of this research are to see how much, and for how long, telithromycin and azithromycin get into the fluids and cells of the lung.
Interventions
- DRUG azithromycin
- DRUG Telithromycin
- PROCEDURE bronchoalveolar lavage
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 35 participants |
| Start Date | 2006-01 |
| Est. Completion | 2006-11 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00315601
The ClinicalTrials.gov registry entry for NCT00315601 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 35 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Illinois at Chicago, which has 430 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which azithromycin is the first listed.
NCT00315601 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00315601 about?
NCT00315601 is a clinical study titled "Intrapulmonary Pharmacokinetics of Antibiotics". The major objectives of this research are to see how much, and for how long, telithromycin and azithromycin get into the fluids and cells of the lung.
What is the current status of trial NCT00315601?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 35 participants. The study started on 2006-01. Estimated completion is 2006-11.
What interventions are being tested in trial NCT00315601?
The interventions under investigation include: azithromycin (DRUG), Telithromycin (DRUG), bronchoalveolar lavage (PROCEDURE).
Who is sponsoring clinical trial NCT00315601?
This trial is sponsored by University of Illinois at Chicago, which has 430 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.